SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Kumar Abhishek) "

Sökning: WFRF:(Kumar Abhishek)

  • Resultat 1-10 av 52
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Kassebaum, Nicholas J., et al. (författare)
  • Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015 : a systematic analysis for the Global Burden of Disease Study 2015
  • 2016
  • Ingår i: The Lancet. - 0140-6736 .- 1474-547X. ; 388:10053, s. 1603-1658
  • Tidskriftsartikel (refereegranskat)abstract
    • Background Healthy life expectancy (HALE) and disability-adjusted life-years (DALYs) provide summary measures of health across geographies and time that can inform assessments of epidemiological patterns and health system performance, help to prioritise investments in research and development, and monitor progress toward the Sustainable Development Goals (SDGs). We aimed to provide updated HALE and DALYs for geographies worldwide and evaluate how disease burden changes with development. Methods We used results from the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015) for all-cause mortality, cause-specific mortality, and non-fatal disease burden to derive HALE and DALYs by sex for 195 countries and territories from 1990 to 2015. We calculated DALYs by summing years of life lost (YLLs) and years of life lived with disability (YLDs) for each geography, age group, sex, and year. We estimated HALE using the Sullivan method, which draws from age-specific death rates and YLDs per capita. We then assessed how observed levels of DALYs and HALE differed from expected trends calculated with the Socio-demographic Index (SDI), a composite indicator constructed from measures of income per capita, average years of schooling, and total fertility rate. Findings Total global DALYs remained largely unchanged from 1990 to 2015, with decreases in communicable, neonatal, maternal, and nutritional (Group 1) disease DALYs off set by increased DALYs due to non-communicable diseases (NCDs). Much of this epidemiological transition was caused by changes in population growth and ageing, but it was accelerated by widespread improvements in SDI that also correlated strongly with the increasing importance of NCDs. Both total DALYs and age-standardised DALY rates due to most Group 1 causes significantly decreased by 2015, and although total burden climbed for the majority of NCDs, age-standardised DALY rates due to NCDs declined. Nonetheless, age-standardised DALY rates due to several high-burden NCDs (including osteoarthritis, drug use disorders, depression, diabetes, congenital birth defects, and skin, oral, and sense organ diseases) either increased or remained unchanged, leading to increases in their relative ranking in many geographies. From 2005 to 2015, HALE at birth increased by an average of 2.9 years (95% uncertainty interval 2.9-3.0) for men and 3.5 years (3.4-3.7) for women, while HALE at age 65 years improved by 0.85 years (0.78-0.92) and 1.2 years (1.1-1.3), respectively. Rising SDI was associated with consistently higher HALE and a somewhat smaller proportion of life spent with functional health loss; however, rising SDI was related to increases in total disability. Many countries and territories in central America and eastern sub-Saharan Africa had increasingly lower rates of disease burden than expected given their SDI. At the same time, a subset of geographies recorded a growing gap between observed and expected levels of DALYs, a trend driven mainly by rising burden due to war, interpersonal violence, and various NCDs. Interpretation Health is improving globally, but this means more populations are spending more time with functional health loss, an absolute expansion of morbidity. The proportion of life spent in ill health decreases somewhat with increasing SDI, a relative compression of morbidity, which supports continued efforts to elevate personal income, improve education, and limit fertility. Our analysis of DALYs and HALE and their relationship to SDI represents a robust framework on which to benchmark geography-specific health performance and SDG progress. Country-specific drivers of disease burden, particularly for causes with higher-than-expected DALYs, should inform financial and research investments, prevention efforts, health policies, and health system improvement initiatives for all countries along the development continuum.
  •  
3.
  • Singh, Om Prakash, et al. (författare)
  • Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India : a transmission-dynamics study
  • 2021
  • Ingår i: The Lancet Microbe. - : Elsevier. - 2666-5247. ; 2:1, s. e23-e31
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Visceral leishmaniasis, also known on the Indian subcontinent as kala-azar, is a fatal form of leishmaniasis caused by the protozoan parasite Leishmania donovani and transmitted by the bites of the vector sandfly Phlebotomus argentipes. To achieve and sustain elimination of visceral leishmaniasis, the transmission potential of individuals exposed to L donovani from across the infection spectrum needs to be elucidated. The aim of this study was to evaluate the relative infectiousness to the sandfly vector of patients with visceral leishmaniasis or post-kala-azar dermal leishmaniasis, before and after treatment, and individuals with asymptomatic infection.Methods: In this prospective xenodiagnosis study done in Muzaffarpur district of Bihar, India, we included patients with clinically confirmed active visceral leishmaniasis or post-kala-azar dermal leishmaniasis who presented to the Kala-Azar Medical Research Center. These participants received treatment for L donovani infection. We also included asymptomatic individuals identified through a serosurvey of 17 254 people living in 26 high-transmission clusters. Eligible participants were aged 12–64 years, were HIV negative, and had clinically or serologically confirmed L donovani infection. During xenodiagnosis, the forearms or lower legs of participants were exposed to 30–35 female P argentipes sandflies for 30 min. Blood-engorged flies were held in an environmental cabinet at 28°C and 85% humidity for 60–72 h, after which flies were dissected and evaluated for L donovani infection by microscopy and quantitative PCR (qPCR). The primary endpoint was the proportion of participants with visceral leishmaniasis or post-kala-azar dermal leishmaniasis, before and after treatment, as well as asymptomatic individuals, who were infectious to sandflies, with a participant considered infectious if promastigotes were observed in one or more individual flies by microscopy, or if one or more of the pools of flies tested positive by qPCR.Findings: Between July 12, 2016, and March 19, 2019, we recruited 287 individuals, including 77 with active visceral leishmaniasis, 26 with post-kala-azar dermal leishmaniasis, and 184 with asymptomatic infection. Of the patients with active visceral leishmaniasis, 42 (55%) were deemed infectious to sandflies by microscopy and 60 (78%) by qPCR before treatment. No patient with visceral leishmaniasis was found to be infectious by microscopy at 30 days after treatment, although six (8%) were still positive by qPCR. Before treatment, 11 (42%) of 26 patients with post-kala-azar dermal leishmaniasis were deemed infectious to sandflies by microscopy and 23 (88%) by qPCR. Of 23 patients who were available for xenodiagnosis after treatment, one remained infectious to flies by qPCR on the pooled flies, but none remained positive by microscopy. None of the 184 asymptomatic participants were infectious to sandflies.Interpretation: These findings confirm that patients with active visceral leishmaniasis and patients with post-kala-azar dermal leishmaniasis can transmit L donovani to the sandfly vector and suggest that early diagnosis and treatment could effectively remove these individuals as infection reservoirs. An important role for asymptomatic individuals in the maintenance of the transmission cycle is not supported by these data. Funding: Bill & Melinda Gates Foundation.
  •  
4.
  • Wang, Haidong, et al. (författare)
  • Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015 : a systematic analysis for the Global Burden of Disease Study 2015
  • 2016
  • Ingår i: The Lancet. - 0140-6736 .- 1474-547X. ; 388:10053, s. 1459-1544
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015. These results informed an in-depth investigation of observed and expected mortality patterns based on sociodemographic measures.METHODS: We estimated all-cause mortality by age, sex, geography, and year using an improved analytical approach originally developed for GBD 2013 and GBD 2010. Improvements included refinements to the estimation of child and adult mortality and corresponding uncertainty, parameter selection for under-5 mortality synthesis by spatiotemporal Gaussian process regression, and sibling history data processing. We also expanded the database of vital registration, survey, and census data to 14 294 geography-year datapoints. For GBD 2015, eight causes, including Ebola virus disease, were added to the previous GBD cause list for mortality. We used six modelling approaches to assess cause-specific mortality, with the Cause of Death Ensemble Model (CODEm) generating estimates for most causes. We used a series of novel analyses to systematically quantify the drivers of trends in mortality across geographies. First, we assessed observed and expected levels and trends of cause-specific mortality as they relate to the Socio-demographic Index (SDI), a summary indicator derived from measures of income per capita, educational attainment, and fertility. Second, we examined factors affecting total mortality patterns through a series of counterfactual scenarios, testing the magnitude by which population growth, population age structures, and epidemiological changes contributed to shifts in mortality. Finally, we attributed changes in life expectancy to changes in cause of death. We documented each step of the GBD 2015 estimation processes, as well as data sources, in accordance with Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER).FINDINGS: Globally, life expectancy from birth increased from 61·7 years (95% uncertainty interval 61·4-61·9) in 1980 to 71·8 years (71·5-72·2) in 2015. Several countries in sub-Saharan Africa had very large gains in life expectancy from 2005 to 2015, rebounding from an era of exceedingly high loss of life due to HIV/AIDS. At the same time, many geographies saw life expectancy stagnate or decline, particularly for men and in countries with rising mortality from war or interpersonal violence. From 2005 to 2015, male life expectancy in Syria dropped by 11·3 years (3·7-17·4), to 62·6 years (56·5-70·2). Total deaths increased by 4·1% (2·6-5·6) from 2005 to 2015, rising to 55·8 million (54·9 million to 56·6 million) in 2015, but age-standardised death rates fell by 17·0% (15·8-18·1) during this time, underscoring changes in population growth and shifts in global age structures. The result was similar for non-communicable diseases (NCDs), with total deaths from these causes increasing by 14·1% (12·6-16·0) to 39·8 million (39·2 million to 40·5 million) in 2015, whereas age-standardised rates decreased by 13·1% (11·9-14·3). Globally, this mortality pattern emerged for several NCDs, including several types of cancer, ischaemic heart disease, cirrhosis, and Alzheimer's disease and other dementias. By contrast, both total deaths and age-standardised death rates due to communicable, maternal, neonatal, and nutritional conditions significantly declined from 2005 to 2015, gains largely attributable to decreases in mortality rates due to HIV/AIDS (42·1%, 39·1-44·6), malaria (43·1%, 34·7-51·8), neonatal preterm birth complications (29·8%, 24·8-34·9), and maternal disorders (29·1%, 19·3-37·1). Progress was slower for several causes, such as lower respiratory infections and nutritional deficiencies, whereas deaths increased for others, including dengue and drug use disorders. Age-standardised death rates due to injuries significantly declined from 2005 to 2015, yet interpersonal violence and war claimed increasingly more lives in some regions, particularly in the Middle East. In 2015, rotaviral enteritis (rotavirus) was the leading cause of under-5 deaths due to diarrhoea (146 000 deaths, 118 000-183 000) and pneumococcal pneumonia was the leading cause of under-5 deaths due to lower respiratory infections (393 000 deaths, 228 000-532 000), although pathogen-specific mortality varied by region. Globally, the effects of population growth, ageing, and changes in age-standardised death rates substantially differed by cause. Our analyses on the expected associations between cause-specific mortality and SDI show the regular shifts in cause of death composition and population age structure with rising SDI. Country patterns of premature mortality (measured as years of life lost [YLLs]) and how they differ from the level expected on the basis of SDI alone revealed distinct but highly heterogeneous patterns by region and country or territory. Ischaemic heart disease, stroke, and diabetes were among the leading causes of YLLs in most regions, but in many cases, intraregional results sharply diverged for ratios of observed and expected YLLs based on SDI. Communicable, maternal, neonatal, and nutritional diseases caused the most YLLs throughout sub-Saharan Africa, with observed YLLs far exceeding expected YLLs for countries in which malaria or HIV/AIDS remained the leading causes of early death.INTERPRETATION: At the global scale, age-specific mortality has steadily improved over the past 35 years; this pattern of general progress continued in the past decade. Progress has been faster in most countries than expected on the basis of development measured by the SDI. Against this background of progress, some countries have seen falls in life expectancy, and age-standardised death rates for some causes are increasing. Despite progress in reducing age-standardised death rates, population growth and ageing mean that the number of deaths from most non-communicable causes are increasing in most countries, putting increased demands on health systems.
  •  
5.
  • Abbasi, Rasha, et al. (författare)
  • IceCube search for neutrinos from GRB 221009A
  • 2023
  • Ingår i: Proceedings of 38th International Cosmic Ray Conference (ICRC 2023). - : Sissa Medialab Srl.
  • Konferensbidrag (refereegranskat)abstract
    •  GRB 221009A is the brightest Gamma Ray Burst (GRB) ever observed. The observed extremelyhigh flux of high and very-high-energy photons provide a unique opportunity to probe the predictedneutrino counterpart to the electromagnetic emission. We have used a variety of methods to searchfor neutrinos in coincidence with the GRB over several time windows during the precursor, promptand afterglow phases of the GRB. MeV scale neutrinos are studied using photo-multiplier ratescalers which are normally used to search for galactic core-collapse supernovae neutrinos. GeVneutrinos are searched starting with DeepCore triggers. These events don’t have directionallocalization, but instead can indicate an excess in the rate of events. 10 GeV - 1 TeV and >TeVneutrinos are searched using traditional neutrino point source methods which take into accountthe direction and time of events with DeepCore and the entire IceCube detector respectively. The>TeV results include both a fast-response analysis conducted by IceCube in real-time with timewindows of T0 − 1 to T0 + 2 hours and T0 ± 1 day around the time of GRB 221009A, as well asan offline analysis with 3 new time windows up to a time window of T0 − 1 to T0 + 14 days, thelongest time period we consider. The combination of observations by IceCube covers 9 ordersof magnitude in neutrino energy, from MeV to PeV, placing upper limits across the range forpredicted neutrino emission.
  •  
6.
  •  
7.
  • Agarwala, Sunita, et al. (författare)
  • Convolutional Neural Networks for Efficient Localization of Interstitial Lung Disease Patterns in HRCT Images
  • 2018
  • Ingår i: Medical Image Understanding and Analysis. - Cham : Springer Nature. - 9783319959214 - 9783319959207 ; , s. 12-22
  • Konferensbidrag (refereegranskat)abstract
    • Lung field segmentation is the first step towards the development of any computer aided diagnosis (CAD) system for interstitial lung diseases (ILD) observed in chest high resolution computed tomography (HRCT) images. If the segmentation is not done efficiently it will compromise the accuracy of CAD system. In this paper, a deep learning-based method is proposed to localize several interstitial lung disease patterns (ILD) in HRCT images without performing lung field segmentation. In this paper, localization of several ILD patterns is performed in image slice. The pretrained models of ZF and VGG networks were fine-tuned in order to localize ILD patterns using Faster R-CNN framework. The three most difficult ILD patterns consolidation, emphysema, and fibrosis have been used for this study and the accuracy of the method has been evaluated in terms of mean average precision (mAP) and free receiver operating characteristic (FROC) curve. The model achieved mAP value of 75% and 83% on ZF and VGG networks, respectively. The result obtained shows the effectiveness of the method in the localization of different ILD patterns.
  •  
8.
  • Husain, Sajid, et al. (författare)
  • Spin pumping in the Hensler alloy Co2FeAl/MoS2 heterostructure : Ferromagnetic resonance experiment and theory
  • 2018
  • Ingår i: Physical Review B. - : AMER PHYSICAL SOC. - 2469-9950 .- 2469-9969. ; 98:18
  • Tidskriftsartikel (refereegranskat)abstract
    • Spin pumping from the full Heusler alloy Co2FeAl film into the transition-metal dichalcogenide MoS2 is reported. Plasma-assisted sulfurization of ion-beam sputtered Mo films of different nominal thicknesses is employed to first fabricate large area high-quality MoS2 sheets [thicknesses: 1, 2, 3, and 4 monolayers (MLs)] on SiO2/Si substrates, followed by deposition of Co2FeAl films with a fixed thickness of 8 nm. The spin pumping is investigated by measuring the changes in the damping constant in the Al(5 nm) capped Co2FeAl/MoS2 bilayers using ferromagnetic resonance spectroscopy. The study demonstrates that even 1 ML of MoS2 possesses high enough spin-orbit coupling strength to enhance damping from 5.5(+/- 0.2) x 10(-3) in Al(5 nm)/Co2FeAl(8 nm) to a nearly saturated value of 8.3(+/- 0.2) x 10(-3) in Al(5 nm)/Co2FeAl(8 nm)/MoS2(1 ML), which is suppressed by inserting a thin Al layer at the Co-2 FeAl/MoS2 interface. The observed enhancement in damping is in agreement with the results from first-principles calculations based on density functional theory. These results open up a paradigm for designing spintronic devices based on heterostructures comprising a full Heusler alloy and the inherently stable MoS2.
  •  
9.
  • Kumar, Abhishek, et al. (författare)
  • Segmentation of Lung Field in HRCT Images Using U-Net Based Fully Convolutional Networks
  • 2018
  • Ingår i: Medical Image Understanding and Analysis. - Cham : Springer Nature. - 9783319959214 - 9783319959207 ; , s. 84-93
  • Konferensbidrag (refereegranskat)abstract
    • Segmentation is a preliminary step towards the development of automated computer aided diagnosis system (CAD). The system accuracy and efficiency primarily depend on the accurate segmentation result. Effective lung field segmentation is major challenging task, especially in the presence of different types of interstitial lung diseases (ILD). At present, high resolution computed tomography (HRCT) is considered to be the best imaging modality to observe ILD patterns. The most common patterns based on their textural appearances are consolidation, emphysema, fibrosis, ground glass opacity (GGO), reticulation and micronodules. In this paper, automatic lung field segmentation of pathological lung has been done using U-Net based deep convolutional networks. Our proposed model has been evaluated on publicly available MedGIFT database. The segmentation result was evaluated in terms of the dice similarity coefficient (DSC). Finally, the experimental results obtained on 330 testing images of different patterns achieving 94% of average DSC.
  •  
10.
  • Meghwanshi, Gautam Kumar, et al. (författare)
  • Enzymes for pharmaceutical and therapeutic applications
  • 2020
  • Ingår i: Biotechnology and applied biochemistry. - : John Wiley & Sons. - 0885-4513 .- 1470-8744. ; 67:4, s. 586-601
  • Forskningsöversikt (refereegranskat)abstract
    • Enzymes are highly efficient and selective biocatalysts, present in the living beings. They exist in enormous varieties in terms of the types of reactions catalyzed by them for instance oxidation-reduction, group transfers within the molecules or between the molecules, hydrolysis, isomerization, ligation, bond cleavage, and bond formation. Besides, enzyme based catalyses are performed with much higher fidelity, under mild reaction conditions and are highly efficient in terms of number of steps, giving them an edge over their chemical counter parts. The unique characteristics of enzymes makes them highly applicable fora number of chemical transformation reactions in pharmaceutical industries, such as group protection and deprotection, selective acylation and deacylation, selective hydrolysis, deracemization, kinetic resolution of racemic mixtures, esterification, transesterification, and many others. In this review, an overview of the enzymes, their production and their applications in pharmaceutical syntheses and enzyme therapies are presented with diagrams, reaction schemes and table for easy understanding of the readers.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 52
Typ av publikation
tidskriftsartikel (42)
konferensbidrag (7)
forskningsöversikt (3)
Typ av innehåll
refereegranskat (52)
Författare/redaktör
Liu, Yang (5)
Trulsson, Mats (4)
Svensson, Peter (4)
Larsson, Anders (3)
Hankey, Graeme J. (3)
McKee, Martin (3)
visa fler...
Petzold, Max, 1973 (3)
Weiderpass, Elisabet ... (3)
Afshin, Ashkan (3)
Abbafati, Cristiana (3)
Badawi, Alaa (3)
Bernabe, Eduardo (3)
Dandona, Lalit (3)
Dandona, Rakhi (3)
Esteghamati, Alireza (3)
Farzadfar, Farshad (3)
Feigin, Valery L. (3)
Forouzanfar, Mohamma ... (3)
Geleijnse, Johanna M ... (3)
Gillum, Richard F. (3)
Jonas, Jost B. (3)
Khang, Young-Ho (3)
Kokubo, Yoshihiro (3)
Kumar, G. Anil (3)
Lopez, Alan D. (3)
Lotufo, Paulo A. (3)
Lozano, Rafael (3)
Malekzadeh, Reza (3)
Mendoza, Walter (3)
Miller, Ted R. (3)
Mokdad, Ali H. (3)
Naghavi, Mohsen (3)
Pereira, David M. (3)
Sepanlou, Sadaf G. (3)
Thorne-Lyman, Andrew ... (3)
Thrift, Amanda G. (3)
Vollset, Stein Emil (3)
Vos, Theo (3)
Werdecker, Andrea (3)
Xu, Gelin (3)
Yonemoto, Naohiro (3)
Estep, Kara (3)
Moradi-Lakeh, Maziar (3)
Amare, Azmeraw T. (3)
Banerjee, Amitava (3)
Bennett, Derrick A. (3)
Dharmaratne, Samath ... (3)
Eshrati, Babak (3)
Goto, Atsushi (3)
Hafezi-Nejad, Nima (3)
visa färre...
Lärosäte
Uppsala universitet (20)
Karolinska Institutet (13)
Lunds universitet (10)
Göteborgs universitet (9)
Umeå universitet (7)
Stockholms universitet (6)
visa fler...
Kungliga Tekniska Högskolan (4)
Luleå tekniska universitet (3)
Malmö universitet (3)
Högskolan Dalarna (3)
Linköpings universitet (2)
Linnéuniversitetet (2)
Sveriges Lantbruksuniversitet (2)
Högskolan Kristianstad (1)
Jönköping University (1)
Mittuniversitetet (1)
visa färre...
Språk
Engelska (52)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (29)
Naturvetenskap (17)
Teknik (9)
Lantbruksvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy